Cancer Management and Research · 2019 · 29 citations · 28 references
MedicineOncologyPharmacologyApoptosisChemotherapyMolecular OncologyApoptosis In CancerApoptosis ResistanceChemotherapy ResistanceColorectal CancerCytotoxic ChemotherapyMalignant NeoplasmsApoptosis Resistance In TumorsApoptotic Signaling In CancerCancer Cell ApoptosisChemotherapy-induced ApoptosisEgfr InhibitionFusobacterium SpeciesMolecular Drug ResistanceOxaliplatin-based Therapy
Objective: Chemotherapy failure derived from drug resistance is the most important reason causing the recurrence in colorectal cancer patients. Therefore, it is necessary to shed light on the mechanism of chemotherapy resistance in colorectal cancer patients. Methods: We looked into the contribution of Fusobacterium nucleatum and ANO1 to chemoresistance in the human colorectal carcinoma cell lines. We silence and overexpress ANO1 in HCT116 and HT29 cells with lentivirus and siRNA knockdown technique in the absence or presence of F. nucleatum , oxaliplatin or 5-fluorouracil (5-FU). ANO1, p-pg, cleaved PARP, cleaved caspase-3, and EGFR expression was measured by Western blot. Cell apoptosis was measured by flow cytometry. Results: We found that F. nucleatum promoted ANO1 expression on colon cancer cells. Moreover, ANO1 prevent colon cancer apoptosis from oxaliplatin and 5-FU. Additionally, knockdown ANO1 expression could block F. nucleatum protective effects and increase the apoptosis effects induced by oxaliplatin and 5-FU. Therefore, F. nucleatum might be biologically involved in the development of colon cancer chemoresistance via ANO1 pathway. Conclusions: Taken together, our findings provide a valuable insight into clinical management and therapy, which may ameliorate colorectal cancer patient outcomes. Keywords: colorectal cancer, F. nucleatum , chemoresistance, 5-fluorouracil, oxaliplatin, ANO1
28
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text
Commensal <i>Bifidobacterium</i> promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Ayelet Sivan, Leticia Corrales, Nathaniel Hubert et al. · Science · 2015 · 3.8K citations · Full text
Medicine, Immunology, Oncology +17
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vétizou, Jonathan M. Pitt, Romain Daillère et al. · Science · 2015 · 3.4K citations · Full text
Life Sciences, Immunology, Oncology +17